Genomes, Transcriptomes, Proteomes, Metabolomes in Bioinformatics Investigating Alzheimer’s Disease

Research Article
Open access

Genomes, Transcriptomes, Proteomes, Metabolomes in Bioinformatics Investigating Alzheimer’s Disease

Conghan Li 1*
  • 1 fisheries college, Ocean university of China, Qingdao, China    
  • *corresponding author liconghan@stu.ouc.edu.cn
Published on 28 April 2023 | https://doi.org/10.54254/2753-8818/4/20220542
TNS Vol.4
ISSN (Print): 2753-8826
ISSN (Online): 2753-8818
ISBN (Print): 978-1-915371-27-0
ISBN (Online): 978-1-915371-28-7

Abstract

Alzheimer’s disease is affecting many people, especially people older than 65, living in the world. However, the cause and cure of these disease continue to confuse the scientists. Omics analysis, which includes four levels: genomes, transcriptomes, proteomes and metabolomes analysis, can dig out the information lying behind large amount of data and it’s really useful for complex disease like AD (Alzheimer’s Disease). In this article, I talked about the four levels of omics analysis investigating AD in details. In each level, the general workflow, the information we can get and the examples in AD have been involved. This paper will give the readers a general view of the function of omics analysis in AD.

Keywords:

Genomes, metabolomes, transcriptomes, Alzheimer’s Disease, proteomes

Li,C. (2023). Genomes, Transcriptomes, Proteomes, Metabolomes in Bioinformatics Investigating Alzheimer’s Disease. Theoretical and Natural Science,4,175-181.
Export citation

References

[1]. Simon, R.P., M.J. Aminoff, and D.A. Greenberg, Clinical neurology. 2009: Lange Medical Books/McGraw-Hill.

[2]. Matthews, K.A., et al., Alzheimer's & Dementia. 15(1) 17-24 (2019).

[3]. Tan, M.S., et al., Computers in biology and medicine. 139 104947 (2021).

[4]. Vaz, M. and S. Silvestre, European Journal of Pharmacology. 887 173554 (2020).

[5]. Carrasquillo, M.M., et al., Journal of Alzheimer's Disease. 24(4) 751-758 (2011).

[6]. Uffelmann, E., et al., Nature Reviews Methods Primers. 1(1) 1-21 (2021).

[7]. Huang, X., et al., BMC neurology. 18(1) 1-8 (2018).

[8]. Park, C., J. Ha, and S. Park, Expert Systems with Applications. 140 112873 (2020).

[9]. Subramanian, A., et al., Proceedings of the National Academy of Sciences. 102(43) 15545-15550 (2005).

[10]. Mattick, J.S. and I.V. Makunin, Human molecular genetics. 15(suppl_1) R17-R29 (2006).

[11]. Zhang, B., et al., Cell. 153(3) 707-720 (2013).

[12]. Müller, M., et al., Neurobiology of aging. 35(1) 152-158 (2014).

[13]. Skillbäck, T., et al., Alzheimer's research & therapy. 5(5) 1-10 (2013).

[14]. Johnson, E.C., et al., Molecular neurodegeneration. 13(1) 1-22 (2018).

[15]. Villas-Boas, S.G., et al., Metabolome analysis: an introduction. 2007: John Wiley & Sons.

[16]. Fernie, A.R., Phytochemistry. 68(22-24) 2861-2880 (2007).

[17]. González-Domínguez, R., T. García-Barrera, and J.-L. Gómez-Ariza, Chemical Papers. 66(9) 829-835 (2012).


Cite this article

Li,C. (2023). Genomes, Transcriptomes, Proteomes, Metabolomes in Bioinformatics Investigating Alzheimer’s Disease. Theoretical and Natural Science,4,175-181.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About volume

Volume title: Proceedings of the 2nd International Conference on Biological Engineering and Medical Science (ICBioMed 2022), Part II

ISBN:978-1-915371-27-0(Print) / 978-1-915371-28-7(Online)
Editor:Gary Royle, Steven M. Lipkin
Conference website: http://www.icbiomed.org
Conference date: 7 November 2022
Series: Theoretical and Natural Science
Volume number: Vol.4
ISSN:2753-8818(Print) / 2753-8826(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).

References

[1]. Simon, R.P., M.J. Aminoff, and D.A. Greenberg, Clinical neurology. 2009: Lange Medical Books/McGraw-Hill.

[2]. Matthews, K.A., et al., Alzheimer's & Dementia. 15(1) 17-24 (2019).

[3]. Tan, M.S., et al., Computers in biology and medicine. 139 104947 (2021).

[4]. Vaz, M. and S. Silvestre, European Journal of Pharmacology. 887 173554 (2020).

[5]. Carrasquillo, M.M., et al., Journal of Alzheimer's Disease. 24(4) 751-758 (2011).

[6]. Uffelmann, E., et al., Nature Reviews Methods Primers. 1(1) 1-21 (2021).

[7]. Huang, X., et al., BMC neurology. 18(1) 1-8 (2018).

[8]. Park, C., J. Ha, and S. Park, Expert Systems with Applications. 140 112873 (2020).

[9]. Subramanian, A., et al., Proceedings of the National Academy of Sciences. 102(43) 15545-15550 (2005).

[10]. Mattick, J.S. and I.V. Makunin, Human molecular genetics. 15(suppl_1) R17-R29 (2006).

[11]. Zhang, B., et al., Cell. 153(3) 707-720 (2013).

[12]. Müller, M., et al., Neurobiology of aging. 35(1) 152-158 (2014).

[13]. Skillbäck, T., et al., Alzheimer's research & therapy. 5(5) 1-10 (2013).

[14]. Johnson, E.C., et al., Molecular neurodegeneration. 13(1) 1-22 (2018).

[15]. Villas-Boas, S.G., et al., Metabolome analysis: an introduction. 2007: John Wiley & Sons.

[16]. Fernie, A.R., Phytochemistry. 68(22-24) 2861-2880 (2007).

[17]. González-Domínguez, R., T. García-Barrera, and J.-L. Gómez-Ariza, Chemical Papers. 66(9) 829-835 (2012).